Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

This observational cohort study (n=30) explored perceptions of MDMA-Assisted Therapy among veterans with PTSD.

Conducted by Albany Research Institute, Inc., the study aimed to gather qualitative and quantitative data through interviews and questionnaires with veterans enrolled in VA care.

Participants, aged 18 and older, with an active diagnosis of PTSD, were included. They engaged in recorded interviews where they completed a brief story starter involving a fictitious character offered MDMA-Assisted Therapy. The interviews were transcribed, and recurring themes were identified through thematic analysis.

The primary outcomes measured included screening tools for depressive and PTSD symptoms, such as the Patient Health Questionnaire 9 and PTSD Checklist for DSM-5. The study, which started in August 2022 and concluded in March 2023, was conducted at Stratton VA Medical Center in Albany, New York.

Topic PTSD
Compound MDMA
Country United States of America
Visit trial

Trial Details



Trial Number

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.